scispace - formally typeset
Journal ArticleDOI

Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP‐5‐IgG

Reads0
Chats0
TLDR
Positive serology obviates the need for vitreous biopsy and expedites the search for cancer, as CRMP‐5‐IgG defines a paraneoplastic ophthalmological entity of combined optic neuritis and retinitis with Vitreous inflammatory cells.
Abstract
Autoantibodies have defined two paraneoplastic visual disorders related to small-cell lung carcinoma: retinopathy ("CAR"-IgG [23kDa, recoverin]) and optic neuritis collapsin response-mediated protein 5 (CRMP-5-IgG [62kDa]). Among 16 patients with CRMP-5-IgG and optic neuritis (aged 52-74 years; all smokers, 9 women), we documented coexisting retinitis in 5. None had CAR-IgG. Fifteen had subacute vision loss, swollen optic discs, and field defects. Vascular leakage was evident at and remote from the disc; 5/5 tested had abnormal electroretinograms. Nine had striking vitreous cells. Vitrectomy showed reactive lymphocytosis (4/4), predominantly CD4(+) (1/1). Most patients had multifocal neurological accompaniments. Cerebrospinal fluid contained lymphocytes (7-32), elevated protein, multiple oligoclonal immunoglobulin bands, and CRMP-5-IgG. Three patients superficially resembled Devic's disease at presentation. One autopsied patient had predominantly CD8(+) T lymphocytes infiltrating optic nerve and spinal cord. Eleven patients had confirmed small-cell carcinoma; 1 had imaging evidence of lung cancer; 3 had renal or thyroid carcinoma. Full-length CRMP-5 protein was identified in normal retina and optic nerve by Western blot analyses. Photoreceptor cells, retinal ganglion cells, and nerve fibers exhibited CRMP-5-specific immunoreactivity. In summary, CRMP-5-IgG defines a paraneoplastic ophthalmological entity of combined optic neuritis and retinitis with vitreous inflammatory cells. Positive serology obviates the need for vitreous biopsy and expedites the search for cancer.

read more

Citations
More filters
Journal ArticleDOI

Paraneoplastic Syndromes Involving the Nervous System

TL;DR: Paraneoplastic neurologic syndromes are incited by a tumor outside the nervous system that produces a characteristic antigen of the nervous System that damages nerve tissue and inhibits growth of the tumor.
Journal ArticleDOI

Neuronal autoantigens—pathogenesis, associated disorders and antibody testing

TL;DR: The various targets of neuronal antibodies are reviewed, focusing predominantly on autoantigens located on the cell surface or synapses, and an algorithm to identify and assess antibodies that bind to cell-surface and synaptic antigens is provided.
Journal ArticleDOI

AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance

TL;DR: The latest evidence in support of a direct involvement of AQP4-Ab in the immunopathogenesis of NMO is summarized, the diagnostic tests currently available for the detection of this serum reactivity are critically appraised and a strong rationale for the use of therapies targeted against B cells or antibodies in the treatment of N MO is provided.
Journal ArticleDOI

Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study

TL;DR: Eculizumab seems to be well tolerated, significantly reduce attack frequency, and stabilise or improve neurological disability measures in patients with aggressive neuromyelitis optica spectrum disorders.
Journal ArticleDOI

The Diagnosis and Treatment of Autoimmune Encephalitis

TL;DR: Most forms of autoimmune encephalitis respond to immune therapies, although powerful immune suppression for weeks or months may be needed in difficult cases, and follow-up care is important.
References
More filters
Journal ArticleDOI

Calcium-Channel Antibodies in the Lambert–Eaton Syndrome and Other Paraneoplastic Syndromes

TL;DR: The high frequency of P/Q-type calcium-channel antibodies found in patients with Lambert-Eaton syndrome implies that antibodies of this specificity have a role in the presynaptic pathophysiology of this disorder.
Journal ArticleDOI

CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity.

TL;DR: A new paraneoplastic immunoglobulin G (IgG) autoantibody specific for CRMP‐5, a previously unknown 62‐kd neuronal cytoplasmic protein of the collapsin response‐mediator family, which is in adult central and peripheral neurons, including synapses, and in small‐cell lung carcinomas.
Journal ArticleDOI

Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases.

TL;DR: In MS, damage of axons is closely linked to the CD8(+) CTLs, and protection against CTL-mediated damage should be considered as a new therapeutic approach in MS and other neuroinflammatory diseases.
Journal ArticleDOI

Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies

TL;DR: Seropositivity for ANNA-1 can expedite the diagnosis and treatment of otherwise occult cancer in patients, especially tobacco abusers, with varied neurologic and gastroenterologic presentations.
Journal ArticleDOI

Tumor-specific killer cells in paraneoplastic cerebellar degeneration

TL;DR: Results indicate a model whereby immature dendritic cells that engulf apoptotic tumor cells can mature and migrate to draining lymph organs where they could induce a CTL response to tissue-restricted antigens in PCD, and peripheral activation of cdr2-specific CTLs is likely to contribute to the subsequent development of the autoimmune neuronal degeneration.
Related Papers (5)